Posts Tagged ‘bevacizumab’

January 6th, 2011

Bevacizumab in Breast Cancer Linked to Increase in Heart Failure Risk

A meta-analysis in the Journal of Clinical Oncology suggests that bevacizumab (Avastin) significantly raises the risk for heart failure when given to patients with breast cancer. Toni Choueiri and colleagues analyzed data from 3,784 patients and found a significant increase in the incidence of heart failure among those taking bevacizumab compared with those taking placebo […]